Sort
11,323 grants matching “glioblastoma”
Biomarkers of survival in glioma epidemiology
$464,455John K. Wiencke · University Of California, San Francisco · R01 · FY2009 · CA
Mechanisms of targeting cellular self-renewal in glioblastoma
$464,444Hatem Sabaawy · Rbhs -Cancer Institute Of New Jersey · R01 · FY2020 · CA
Signal Transduction Pathways in Glioblastoma
$464,424Arnab Chakravarti · Ohio State University · R01 · FY2009 · CA
Large Animal Pre-clinical Models
$464,369John Henry Rossmeisl · Wake Forest University Health Sciences · P01 · FY2020 · CA
MYC-dependent loss of splicing fidelity in Glioblastoma multiforme
$464,304Patrick Paddison · Fred Hutchinson Cancer Research Center · R01 · FY2015 · CA
Role of NKCC1 on Brain Tumor Stem Cell Migration After EGF and Slit-2 Stimulation
$464,279Alfredo Quinones-Hinojosa · Johns Hopkins University · R01 · FY2013 · NS
THERAPEUTIC POTENCY TESTING USING A PERFUSABLE MULTINICHE GLIOBLASTOMA-ON-CHIP PLATFORM
$464,165University Of Georgia Research Foundation, Inc. · · FY2024 · Defense Health Agency
Radiation-induced vascular reprogramming in glioblastoma
$464,144Harley I Kornblum · University Of California Los Angeles · R01 · FY2023 · NS
Radiation-induced vascular reprogramming in glioblastoma
$464,144Harley I Kornblum · University Of California Los Angeles · R01 · FY2025 · NS
CDKN2A couples lipid metabolism to ferroptosis in glioblastoma
$464,096David A. Nathanson · University Of California Los Angeles · R01 · FY2025 · NS
Multiscale Resolution and Deep Network Approaches for Deconvolving Different Cell Types in Bulk Tumor using Single-cell Sequencing Data (scDEC)
$464,014Xiaobo Zhou · University Of Texas Hlth Sci Ctr Houston · R01 · FY2019 · CA
Nanoparticles to Track T Cell Immunotherapy Using Magnetic Particle Imaging
$463,812Carlos M Rinaldi-Ramos · University Of Florida · R01 · FY2024 · EB
Targeting Neoantigens in Glioblastoma
$463,723Gavin Peter Dunn · Washington University · R01 · FY2021 · NS
Targeting the Circadian Rhythm in Glioblastoma Stem Cells (R01CA238662)
$463,321Jeremy N Rich · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · CA
Project 2: Exploiting Labile Iron Pools for Improving NSCLC Therapy Using Pharmacological Ascorbate
$462,966Douglas Robert Spitz · University Of Iowa · P01 · FY2019 · CA
Chitinase-3-like-1 mediated immunosuppression in Glioblastoma
$462,773Baoli Hu · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · CA
Iron Based Coupling Media (IBCM) for MRI-guided Transcranial Ultrasound Surgeries
$462,763Steven P Allen · Brigham Young University · R01 · FY2023 · EB
A novel microfluidic device to predict brain cancer prognosis and response to therapy
$462,728Alfredo Quinones-Hinojosa · Mayo Clinic Jacksonville · R01 · FY2022 · CA
Use of CTEP portfolio compounds to counteract phenotype conversion in GBM
$462,651Frank Pajonk · University Of California Los Angeles · R01 · FY2022 · CA
Use of CTEP portfolio compounds to counteract phenotype conversion in GBM
$462,651Frank Pajonk · University Of California Los Angeles · R01 · FY2025 · CA
The Role of Cellular Receptors Involved in Inflammation and Tumor Progression
$462,576Ji Ming Wang · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Retroviral Coded Functions
$462,430Maxine L Linial · Fred Hutchinson Cancer Research Center · R01 · FY2008 · CA
Immobilized Drug Transporters
$462,334Irving William Wainer · National Institute On Aging · ZIA · FY2010 · AG
Systemic Delivery of Targeted Bi-Compartmental Nanoparticles for Glioblastoma Therapeutics
$462,077Joerg Lahann · University Of Michigan At Ann Arbor · R01 · FY2024 · NS
Hematopoietic Chemoprotection in Glioblastoma Patients
$461,965Hans-Peter Kiem · Fred Hutchinson Cancer Research Center · R01 · FY2006 · CA